506U78
Drug timelines are a Plus or Pro feature.
9 regulatory and trial events tracked for 506U78, covering 2013-01-16 to 2022-08-18. Get the full timeline:
Most recent: Clinical Trial Update: 506U78 In Relapsed Or Refractory Acute Lymphoblastic Leukemia (T-ALL) [Phase 2]